Trial of Viagra for fetal growth restriction is halted after baby deaths
BMJ 2018; 362 doi: https://doi.org/10.1136/bmj.k3247 (Published 25 July 2018) Cite this as: BMJ 2018;362:k3247- Nigel Hawkes
- London
A Dutch trial using sildenafil (Viagra) to try to correct fetal growth restriction has been halted after 11 babies subsequently died.
An interim review by an independent committee of the STRIDER trial, which had randomly assigned 183 pregnant women to take sildenafil or placebo, showed that lung complications were more common in the babies born to women given the drug. Of these women, 17 had babies with lung problems: 11 of those babies have since died, compared with three in the placebo group, none of whom died.
A statement from …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.